Helicobacter pylori is an established cause of many gastrointestinal pathologies including peptic ulcer disease, gastritis, and gastric cancer. It is an entity that affects the global population, and its true nature has only been known since the 1980s. Although there is much known about H. pylori including its pathophysiology, detection, and eradication, resistance to current therapy models is common. This is problematic because untreated or inadequately treated H. pylori increases morbidity and mortality related to gastric cancer and peptic ulcer disease among others. In order to improve the treatment and reduce resistance, there is significant ongoing research identifying new detection and eradication methods for H. pylori. This review aims to highlight what has already been established regarding H. pylori’s epidemiology, pathophysiology, detection, and treatment as well as the most current and novel research involving detection and treatment of H. pylori.
Clostridioides difficile infection (CDI) is a potentially life-threatening cause of diarrhea that can result in multiple complications. Fulminant CDI that is nonresponsive to antibiotics may require surgical ileostomy or fecal microbiota transplant (FMT). We present a case of a patient with fulminant CDI requiring surgical loop ileostomy who underwent a successful FMT delivered by Foley catheter through the ileostomy with symptom resolution. Delivery of FMT using a foley catheter in a patient with an ileostomy may be safe and effective for patients who are at a higher risk of complications associated with the instillation of FMT through colonoscopy with anesthesia.
1 October 2019 in American Journal of Gastroenterology
INTRODUCTION: Capecitabine is a fluoropyrimidine chemotherapy agent used in the treatment of colorectal cancer. Gastrointestinal side effects are common, including diarrhea, nausea, vomiting, abdominal pain, severe hepatic impairment, and decreased appetite. Here we report a case of Capecitabine-induced ileitis with severe diarrhea leading to hypovolemic shock and acute kidney injury. The patient was admitted to the intensive care unit (ICU) twice during hospitalization and required cessation of capecitabine. CASE DESCRIPTION/METHODS: Our patient is an 82-year-old male with a history of prostate cancer now with stage IIA rectal adenocarcinoma who was started on Capecitabine neoadjuvant chemotherapy without radiation due to previous pelvic radiotherapy for the prostate cancer. He tolerated the first treatment cycle without any side effects. At the beginning of the 2nd cycle, he reported eight watery non-bloody bowel movements a day. CT abdomen showed wall thickening of multiple loops of the distal small bowel. He was admitted to the ICU, started on vasopressor therapy and broad-spectrum antibiotics, but diarrhea persisted. Physical exam showed mild diffuse abdominal tenderness. Laboratory studies were notable for elevated creatinine but stool culture, ova and parasites, and Clostridium difficile PCR were negative. Antibiotics were stopped and loperamide was started without significant improvement. Gastroenterology was consulted and colonoscopy showed linear ulcers at terminal ileum and ulceration at ileocecal valve - pathology showed active ileitis with ulceration. Diarrhea improved with supportive management and cessation of Capecitabine. DISCUSSION: Although Capecitabine's side effects are mostly well tolerated, they can occasionally lead to prolonged hospitalization and even ICU admission. Capecitabine is not a cytotoxic drug in itself, it is absorbed from the intestine and metabolized in the liver then in the tumor cells by three-step enzymatic cascade to be converted to 5-FU. Capecitabine-induced ileitis has been reported in the literature and was diagnosed by a combination of symptoms, CT scan, colonoscopy, and/or histopathology. The mechanism is reported to be due to the susceptibility of the intestinal vascular endothelium to 5-FU by the generation of free radicals which may lead to a hypercoagulable state. In summary, treating physicians should be aware of this critical side effect and intervene early when diarrhea is reported.
1 August 2017 in Journal of Cardiac Critical Care TSS
The patient is a 55-year-old woman status post two mitral clips with a severely dilated left atrium and persistent severe mitral regurgitation. During a follow-up, an attempt was made to examine the proximal coronary arteries by two-dimensional transthoracic echocardiography[1] [2] [3] ([Videos 1] [2] [3] [4]).
1 October 2019 in American Journal of Gastroenterology
INTRODUCTION: Candida species are a part of normal GI flora however some patients, especially during immunocompromised state can develop Candida esophagitis (CE). Sorafenib is a tyrosine kinase inhibitor commonly used for treatment of renal cell and hepatocellular carcinoma (HCC). We report one of the most severe cases of CE following Sorafenib. CASE DESCRIPTION/METHODS: An 84-year-old man was admitted for a 2-week history of solid food dysphagia with nausea, chocking and regurgitation following food intake. His medical history included type 2 diabetes mellitus and stage IV (T3N0M1) metastatic HCC. Patient had been taking Sorafenib 400mg twice daily for the last 6 months and recently received palliative radiotherapy (RT) for a pathologic pelvic fracture due to bone metastasis. Patient denied any vomiting, odynophagia, anorexia, fever, chills, abdominal pain, diarrhea or constipation. On clinical examination, he had normal vital signs, appeared thin and cachectic, had oral thrush underneath artificial dentures while the rest of the clinical examination was unremarkable. His lab-work showed borderline leukocytosis of 11.9 103/µL, mild anemia with Hb of 10.5 g/dl, and normal electrolytes, renal function and liver integrity enzymes. He underwent an esophagogastroduodenoscopy (EGD) which interestingly showed esophagus completely lined with thick whitish adherent plaques, diffuse atrophic gastropathy and normal duodenum. Despite the esophagus having no tortuosity, rings or strictures, it required considerable amount of force to advance the endoscope through the copious amount of exudate in the esophagus which would explain the patient’s dysphagia. We obtained biopsy and brushing from esophagus which revealed abundant inflammatory cells and fungal organisms consistent with Candida species. Patient was given a loading dose of 400 mg of Fluconazole followed by 200 mg daily for 21 days. After completion of therapy, patient’s symptoms had improved, and he was tolerating a regular diet. DISCUSSION: Upon literature review we found one case series of 2 patients mentioning CE as a side effect with the use of Sorafenib. Unlike above case series in which patients developed CE soon after initiation of Sorafenib, our patient developed symptoms after being on it for 6 months. Physicians should be aware when using Sorafenib that it can induce an immunosuppressive state with an increased risk of CE. Delayed diagnosis and subsequent treatment may affect the nutritional status and subsequently the overall survival in these patients.
1 October 2019 in American Journal of Gastroenterology
INTRODUCTION: Pyogenic liver abscesses are often polymicrobial with Escherichia coli being the most common isolated organism. Klebsiella pneumoniae is a rare cause of pyogenic liver abscesses and often affects patients with immunodeficient states. Here we discuss a rare case of primary Klebsiella pneumoniae liver abscess with subsequent metastatic infection leading to vision loss. CASE DESCRIPTION/METHODS: A 68-year-old African American woman presented with complaints of intermittent fever, chills, right upper quadrant abdominal pain and blurry vision of the left eye. Her past medical history was notable for recent laparoscopic hernia repair, cataract surgery, and hypertension. The abdominal exam showed moderate tenderness of the right upper quadrant; ophthalmic exam of the left eye revealed afferent pupillary defect and decreased visual acuity. Labs were notable for leukocytosis, total bilirubin of 2.7, AST of 161, ALT of 135 and an alkaline phosphatase of 110. CT abdominal imaging revealed an abscess within the dome of the right liver measuring 5.2 × 6.3 × 4.1 cm. She was admitted to the intensive care unit and started on broad-spectrum empiric antibiotic therapy. Blood culture revealed gram-negative rods. B-scan ultrasonography of the left eye showed vitritis with loculation confirming the diagnosis of endophthalmitis. Intravitreal antibiotics were promptly administrated. She underwent CT guided sampling and drainage of the hepatic abscess with fluid culture growing the same organism identified in the blood cultures: mucoid Klebsiella pneumoniae complex. The patient was diagnosed with invasive Klebsiella bacteremia, liver abscess, and endophthalmitis and developed permanent vision loss in the left eye despite prompt intravenous and intravitreal antibiotic therapy. DISCUSSION: Klebsiella pneumoniae invasive liver abscess syndrome is a rare condition in the United States making timely diagnosis and treatment a challenge per se. Known risk factors for invasive liver abscess syndrome include diabetes mellitus, hepatobiliary disease, alcoholism, chronic renal failure, and cancer. While our patient did not have any of these specific comorbidities and had no recent international travel, her age, and recent surgical interventions likely predisposed her to an immunocompromised state. Invasive liver abscess syndrome can be fatal with poor prognosis if treatment is delayed. Timely abscess drainage and administration of intravenous antibiotics is crucial and should be implemented early on in the clinical course.